Senzime

Quality Improvement (QI) programs have become essential in modern healthcare, leveraging real-world data to enhance efficiency and outcomes. Senzime’s TetraGraph system and its unique cloud-based TetraConnect platform offers novel abilities to run anesthesiology-focused QI programs on large patient datasets. By further use of Artificial Intelligence (AI) analysis, additional insights may unlock abilities to improve anesthesia care by a more personalized, data-driven approach to the administration and reversal of neuromuscular blocking agents (NMBAs).

“This marks another milestone for Senzime,” said Philip Siberg, CEO of Senzime. “Not only have we secured one of our largest system-wide installations to date, but this project also serves as a benchmark for hospitals looking to implement QI initiatives in anesthesiology. Our unique solution and experienced team are unlocking the potential of perioperative data at scale. We have a turn-key solution enbaling hospitals to transform how they monitor, manage, and ultimately protect patients during surgery. This is just the beginning of a new era in precise and personalized anesthesia.”

The TetraGraph system is used by anesthesiologists in thousands of operating rooms worldwide and aligns with recently published U.S. and European guidelines recommending quantitative neuromuscular monitoring for all patients receiving NMBAs. The TetraGraph system allows clinicians to accurately assess the depth of neuromuscular block, tailor dosing, and confirm when it is safe for patients to resume spontaneous breathing post-surgery - therby reducing the risk of residual paralysis and enhancing postoperative outcomes.